Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model
- 1 September 2010
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 87 (3) , 361-366
- https://doi.org/10.1016/j.antiviral.2010.06.009
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Oseltamivir Prophylactic Regimens Prevent H5N1 Influenza Morbidity and Mortality in a Ferret ModelThe Journal of Infectious Diseases, 2008
- Update on Avian Influenza A (H5N1) Virus Infection in HumansNew England Journal of Medicine, 2008
- Efficacy of Oseltamivir Therapy in Ferrets Inoculated with Different Clades of H5N1 Influenza VirusAntimicrobial Agents and Chemotherapy, 2007
- Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemiaNature Medicine, 2006
- Oseltamivir Resistance during Treatment of Influenza A (H5N1) InfectionNew England Journal of Medicine, 2005
- Avian influenza A (H5N1)Journal of Clinical Virology, 2005
- Fatal Avian Influenza A (H5N1) in a Child Presenting with Diarrhea Followed by ComaNew England Journal of Medicine, 2005
- Pharmacokinetics of Zanamivir After Intravenous, Oral, Inhaled or Intranasal Administration to Healthy VolunteersClinical Pharmacokinetics, 1999
- Pharmacoscintigraphic Evaluation of Lung Deposition of Inhaled Zanamivir in Healthy VolunteersClinical Pharmacokinetics, 1999
- Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802Clinical Pharmacokinetics, 1999